Literature DB >> 17958793

Melanocytic nevi in 2783 children and adolescents in Turkey.

Gursoy Dogan1.   

Abstract

This study investigated the numbers of melanocytic nevi in Turkish children and adolescents. The research was conducted on 2783 subjects (age range, 7-14 yrs) at three elementary schools in Malatya, Turkey (latitude 38 degrees N). Numbers of melanocytic nevi per subject were counted using a standard international protocol. Comparisons were made with subjects categorized according to age, sex and skin type. The mean melanocytic nevus count was 1.07 +/- 2.37. A significant positive correlation was found between nevus count and age (p < 0.001). The mean count for boys was significantly higher than that for girls (p < 0.001). Subjects with skin type II had a higher mean melanocytic nevus count than the other three groups. This is the first study related to numbers of melanocytic nevi in Turkey. The findings reveal that Turkish children and adolescents have few melanocytic nevi compared to those elsewhere in the world. In line with previous reports on other populations, analysis showed that older age, skin type II, and male sex are associated with higher melanocytic nevus counts. The results underline the importance of ethnic background in melanocytic nevus development.

Entities:  

Mesh:

Year:  2007        PMID: 17958793     DOI: 10.1111/j.1525-1470.2007.00500.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Dermatological Findings in Turkish Paediatric Haematology-Oncology Patients.

Authors:  Umit Uksal; Pinar Ozturk; Emine Colgecen; Nazan Taslidere; Turkan Patiroglu; Mehmet Akif Ozdemir; Yasemin Altuner Torun; Murat Borlu
Journal:  Eurasian J Med       Date:  2016-06

2.  Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system.

Authors:  Alon Scope; Stephen W Dusza; Ashfaq A Marghoob; Jaya M Satagopan; Juliana Braga Casagrande Tavoloni; Estee L Psaty; Martin A Weinstock; Susan A Oliveria; Marilyn Bishop; Alan C Geller; Allan C Halpern
Journal:  J Invest Dermatol       Date:  2011-05-12       Impact factor: 8.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.